Parabilis Medicines Inc. (PBLS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Parabilis Medicines Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$28.17
+6.26% today
Market cap
$3.2B
Overall quality
—
Kronos AI 30-day
+50.0%
8 of 8 simulated paths end higher
Parabilis Medicines Inc. (PBLS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $3.2B. It trades at $28.17, up 6.26% today. 5 analysts' average target of $41.75 implies +48.2% from today's price. Kronos AI's 30-day forecast is +50.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $41.75 |
| Low – high | $40.00 – $45.00 |
| Analysts | 5 |
| Upside to average | +48.2% |
Kronos AI 30-day forecast
| Expected close | $39.75 (+50.0%) |
| Likely range | +37.7% … +55.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.